Top Page
Zentek
(ZEN)
Zentek (ZEN) vs. iShares MSCI Canada ETF (EWC)
Zentek Business Overview & Revenue Model
Zentek Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 924.80K | 872.50K | 29.82K | 72.86K | 339.67K | 2.35K |
| Gross Profit | 234.51K | 192.49K | -385.06K | -780.48K | -275.04K | -124.44K |
| EBITDA | -8.14M | -9.35M | -11.08M | -13.75M | -11.27M | -3.73M |
| Net Income | -8.85M | -10.04M | -11.70M | -14.41M | -38.69M | -3.87M |
Balance Sheet | ||||||
| Total Assets | 18.48M | 18.40M | 22.59M | 33.29M | 37.98M | 30.25M |
| Cash, Cash Equivalents and Short-Term Investments | 2.89M | 121.48K | 3.52M | 10.36M | 26.68M | 3.09M |
| Total Debt | 1.88M | 680.47K | 1.24M | 1.61M | 2.23M | 404.32K |
| Total Liabilities | 4.49M | 3.65M | 2.41M | 2.90M | 3.44M | 2.79M |
| Stockholders Equity | 13.99M | 14.75M | 20.17M | 30.38M | 34.55M | 27.46M |
Cash Flow | ||||||
| Free Cash Flow | -6.09M | -6.28M | -8.37M | -15.23M | -11.97M | -2.05M |
| Operating Cash Flow | -6.04M | -6.28M | -8.05M | -12.96M | -7.99M | -1.79M |
| Investing Cash Flow | 2.69M | 358.65K | 1.88M | -2.31M | -7.25M | -1.23M |
| Financing Cash Flow | 4.30M | 2.52M | -665.47K | -1.05M | 38.82M | 5.31M |
Zentek Technical Analysis
Zentek Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
53 Neutral | C$61.85M | ― | -69.80% | ― | ― | 55.80% | |
52 Neutral | $404.20M | ― | -6.77% | ― | 11.18% | 70.04% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | C$149.45M | ― | -9.96% | ― | -0.70% | -102.48% | |
45 Neutral | $109.95M | ― | -53.76% | ― | 2519.47% | 22.52% | |
45 Neutral | C$422.07M | ― | -158.24% | ― | ― | ― | |
26 Underperform | C$58.83M | ― | ― | ― | ― | 10.49% |
Zentek Corporate Events
Zentek Ltd. has successfully closed a non-brokered private placement of units, raising gross proceeds of $2,479,227. The funds will be allocated for general and administrative corporate purposes. This financial move is expected to bolster the company’s operational capabilities and potentially enhance its market positioning. The offering included common shares and warrants, with certain directors participating, marking it as a related party transaction under regulatory guidelines.
The most recent analyst rating on (TSE:ZEN) stock is a Hold with a C$1.00 price target. To see the full list of analyst forecasts on Zentek stock, see the TSE:ZEN Stock Forecast page.
Zentek Ltd. has announced an increase in its non-brokered private placement to raise up to $2,500,000, with each unit priced at $1.06. The proceeds will be used for working capital and general corporate purposes. Each unit comprises one common share and two half-warrants, which can be converted into common shares at specified prices and conditions. The offering is subject to regulatory approvals and includes a hold period for the issued securities.
The most recent analyst rating on (TSE:ZEN) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on Zentek stock, see the TSE:ZEN Stock Forecast page.
Zentek’s subsidiary, Albany Graphite Corp., announced successful results from nuclear suitability testing of its ultra-high purity graphite, confirming its potential use in the nuclear energy industry. The tests demonstrated that Albany graphite meets or exceeds nuclear-grade requirements in areas such as particle size distribution, compressibility, resistivity, and friction, highlighting its reliability and safety for demanding nuclear applications.
The most recent analyst rating on (TSE:ZEN) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on Zentek stock, see the TSE:ZEN Stock Forecast page.
Zentek Ltd. has announced a non-brokered private placement aiming to raise up to $2,000,000 through the issuance of units priced at $1.06 each. The proceeds will be used for working capital and general corporate purposes. Each unit includes common shares and purchase warrants, with specific terms for Series A and Series B warrants. This move is part of Zentek’s strategy to bolster its financial resources and support its ongoing operations and development projects. Additionally, the company has granted stock options and restricted share units to its officers, directors, and employees, further aligning their interests with the company’s growth objectives.
The most recent analyst rating on (TSE:ZEN) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on Zentek stock, see the TSE:ZEN Stock Forecast page.
Zentek Ltd. announced the successful voting results from its annual and special meeting of shareholders, where all resolutions were approved, including the election of board members and the appointment of BDO Canada LLP as auditors. Notably, John Snisarenko was appointed as the new Chair of the Board, succeeding Eric Wallman. This leadership change is seen as a strategic move to support Zentek’s growth ambitions and enhance shareholder value as the company transitions its CEO and continues to develop its innovative technologies.
The most recent analyst rating on (TSE:ZEN) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on Zentek stock, see the TSE:ZEN Stock Forecast page.
Zentek Ltd. announced a leadership transition with CFO Wendy Ford stepping in as Interim CEO following the resignation of former CEO Greg Fenton. The company is actively searching for a new CEO to guide its next growth phase. Zentek’s ZenGUARD™ Enhanced Air Filters have demonstrated superior performance in removing infectious aerosols, aligning with ASHRAE standards, and are being positioned for widespread adoption in Canada through government procurement and partnerships. This strategic move aims to enhance market penetration and accelerate revenue growth, particularly in sectors like healthcare and education.
The most recent analyst rating on (TSE:ZEN) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on Zentek stock, see the TSE:ZEN Stock Forecast page.
Zentek’s subsidiary, Albany Graphite Corp., has achieved a significant milestone by purifying Albany graphite to an ultra-high 5N purity level, making it suitable for nuclear applications. This development positions Albany graphite as a rare natural alternative to synthetic graphite, with potential implications for the nuclear energy sector, especially as countries like Canada and the U.S. expand their nuclear energy capacities. The purification process, which avoids halogen gases, offers a cost-effective and environmentally friendly solution, enhancing the material’s appeal for high-growth markets.
The most recent analyst rating on (TSE:ZEN) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on Zentek stock, see the TSE:ZEN Stock Forecast page.
Zentek Ltd. has successfully completed the first in vivo tests of its lead candidate countermeasure for seasonal influenza (H1N1) using multivalent aptamer technology. The testing, part of the Innovative Solutions Canada Testing Stream, showed promising results, with treated animals exhibiting improved clinical scores and higher survival rates compared to the control group. This development, supported by a $1.1 million award from the Government of Canada, marks a significant step in Zentek’s efforts to address both seasonal and potentially pandemic influenza strains, positioning the company as a key player in the advanced medical technologies sector.
The most recent analyst rating on (TSE:ZEN) stock is a Hold with a C$1.00 price target. To see the full list of analyst forecasts on Zentek stock, see the TSE:ZEN Stock Forecast page.
Zentek Ltd. has announced an updated slate of independent director nominees for its upcoming annual general and special meeting. The new nominees include Matt Fontes and Pete Gettinby, who bring expertise in building innovation and renewable energy, respectively. This strategic update aims to enhance Zentek’s board with diverse skills and experiences, potentially strengthening its market position and operational capabilities.
The most recent analyst rating on (TSE:ZEN) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on Zentek stock, see the TSE:ZEN Stock Forecast page.
On September 3, 2025, Zentek Ltd. announced the resignation of Greg Fenton as CEO, who will now lead Altek Advanced Materials Inc., a U.S.-based venture. This transition is part of a strategic move to accelerate the commercialization of Zentek’s technologies, including ZenGUARD™, in the U.S. market through a licensing agreement with Altek. The agreement allows Altek to manufacture and commercialize Zentek’s products in the U.S., while Zentek retains its intellectual property rights. This shift is expected to enhance Zentek’s market presence with minimal additional resources. Wendy Ford, the CFO, has been appointed as interim CEO while the company searches for a new leader.
The most recent analyst rating on (TSE:ZEN) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on Zentek stock, see the TSE:ZEN Stock Forecast page.
Zentek Ltd.’s subsidiary, Albany Graphite Corp., has been awarded a $500,000 grant from Ontario’s Critical Minerals Innovation Fund for its Albany Graphite Purification and Anode Material Development Project. This project, which includes collaboration with North American companies and Natural Resources Canada, aims to produce high-purity graphite for use in lithium-ion batteries and nuclear applications. The initiative is part of Ontario’s strategy to strengthen its critical minerals sector and position itself as a leader in clean energy minerals, potentially enhancing Zentek’s market position and investment potential.
The most recent analyst rating on (TSE:ZEN) stock is a Sell with a C$1.00 price target. To see the full list of analyst forecasts on Zentek stock, see the TSE:ZEN Stock Forecast page.
Albany Graphite Corp., a subsidiary of Zentek Ltd., has been awarded a $500,000 grant from Ontario’s Critical Minerals Innovation Fund for its graphite purification and anode material development project. This initiative, which involves collaboration with North American companies and Natural Resources Canada, aims to enhance the production of ultra-high purity graphite for applications in lithium-ion batteries and nuclear technology, potentially strengthening Zentek’s position in the critical minerals market.
The most recent analyst rating on (TSE:ZEN) stock is a Sell with a C$1.00 price target. To see the full list of analyst forecasts on Zentek stock, see the TSE:ZEN Stock Forecast page.
On August 26, 2025, Zentek Ltd. received a notification from Nasdaq indicating non-compliance with the minimum bid price requirement, as its shares have been below US $1.00 for 31 consecutive business days. This notification does not immediately affect the trading of Zentek’s shares, and the company has 180 days to regain compliance. If necessary, Zentek may consider a reverse stock split to meet the requirements. The company’s business operations remain unaffected by this notification.
The most recent analyst rating on (TSE:ZEN) stock is a Sell with a C$1.00 price target. To see the full list of analyst forecasts on Zentek stock, see the TSE:ZEN Stock Forecast page.
Zentek Ltd. announced the distribution of a management information circular and related materials to its shareholders on August 25, 2025, in preparation for its Annual and Special Meeting of Shareholders scheduled for September 25, 2025. The meeting will address several key corporate governance issues, including the election of directors, appointment of auditors, and approval of an omnibus long-term incentive plan. Zentek is utilizing a notice-and-access method for delivering meeting materials, which is environmentally friendly and cost-effective, allowing shareholders to access documents online instead of receiving paper copies.
The most recent analyst rating on (TSE:ZEN) stock is a Sell with a C$1.00 price target. To see the full list of analyst forecasts on Zentek stock, see the TSE:ZEN Stock Forecast page.
Zentek Ltd., a company based in Guelph, Ontario, has released its unaudited condensed interim consolidated financial statements for the three months ending June 30, 2025. The financial report highlights a significant increase in net sales compared to the same period in 2024, indicating improved business performance. However, the company continues to face challenges with a reported loss before other income and expenses. The report also notes changes in liabilities and shareholders’ equity, reflecting ongoing financial adjustments.